What's new

Orphan designation: sutimlimab Treatment of autoimmune haemolytic anaemia, 11/02/2025 Positive

Orphan designation: sutimlimab Treatment of autoimmune haemolytic anaemia, 11/02/2025 Positive

Mar 12, 2025 - 17:04
 0
Orphan designation: sutimlimab Treatment of autoimmune haemolytic anaemia, 11/02/2025 Positive
Read More

Tags:

Previous Article

Rivian launches new hands-free driving feature for Gen 2 EVs

Next Article

Orphan designation: Upifitamab rilsodotin Treatment of ovarian cancer, 09/12/202...

Related Posts

Human medicines European public assessment report (EPAR): MicardisPlus, Date of authorisation: 19/04/2002, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025  0

Orphan designation: hydroxocobalamin acetate Treatment of homocystinuria and/or methylmalonic acidaemia due to genetic defects of intracellular cobalamin processing, 26/02/2025 Positive

Orphan designation: hydroxocobalamin acetate Treatment ...

Mar 11, 2025  0

Human medicines European public assessment report (EPAR): Trimbow, beclometasone,formoterol,glycopyrronium bromide, Date of authorisation: 17/07/2017, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 17, 2025  0